Robert A. Eckert - 31 May 2024 Form 4 Insider Report for AMGEN INC (AMGN)

Role: Director
Signature: /s/ Robert A. Eckert
Issuer symbol: AMGN
Transactions as of: 31 May 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2024, 19:26:26 UTC
Previous filing: 28 May 2024
Next filing: 22 Aug 2024
SEC: View on sec.gov

Key filing fact

Robert A. Eckert filed Form 4 for AMGEN INC (AMGN) on 04 Jun 2024.

Key facts

This page summarizes Robert A. Eckert's Form 4 filing for AMGEN INC (AMGN).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 04 Jun 2024, 19:26.

Change

Previous filing in this sequence was filed on 28 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

AMGN transaction

Common Stock

Award

Transaction value: $0
Shares: +719
Change %: +3.1%
Price: $0.000000
Shares after: 23,715
Date: 31 May 2024
Ownership: Direct
Footnotes: F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
F2	These shares include 2,881 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Content

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

These shares include 2,881 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.